| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23.5B | $21.8B | $22.4B | $21.4B | $18.2B | $4.1B | $2.1B | $2.0B |
| Cost of Revenue | $18.5B | $17.1B | $17.5B | $16.8B | $14.4B | $3.4B | $1.7B | $1.6B |
| Gross Profit | — | — | — | — | — | $0.8B | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.5B | $3.3B | $3.3B | $3.0B | $2.8B | $1.9B | $1.2B | $1.2B |
| Operating Income | $1.2B | $1.2B | $1.4B | $1.4B | $0.8B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.6B | $0.7B | $0.8B | $0.9B | $0.5B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $13.26 | $13.26 | $13.86 | $15.83 | $8.11 | $0.11 | $1.27 | $1.27 |
| EPS (Diluted) | $13.05 | $13.05 | $13.54 | $15.33 | $7.84 | $0.11 | $1.26 | $1.26 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.5B | $15.1B | $15.1B | $14.8B | $12.6B | $11.9B | $5.0B | $4.6B |
| Current Assets | $9.5B | $8.4B | $8.4B | $8.3B | $6.4B | $5.5B | $2.5B | $2.4B |
| Cash & Equivalents | — | — | — | — | $0.2B | $0.4B | $0.2B | $0.1B |
| Total Liabilities | $11.5B | $10.1B | $10.0B | $10.4B | $8.8B | $8.5B | $2.8B | $2.5B |
| Current Liabilities | $4.3B | $3.8B | $3.4B | $3.8B | $3.0B | $3.0B | $1.1B | $1.1B |
| Stockholders' Equity | $5.0B | $5.0B | $5.0B | $4.5B | $3.8B | $3.3B | $2.3B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $1.1B | $0.5B | $0.0B | $0.1B | $0.5B | $0.2B | $0.3B |
| Investing Cash Flow | $-0.1B | $0.0B | $-0.1B | $-0.3B | $0.0B | $-3.7B | $-0.1B | $-0.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.1B | $-0.9B | $-0.4B | $0.6B | $-0.3B | $3.5B | $-0.1B | $-0.3B |